Skip to main content
SpringerLink
Log in

Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease

  • Original Articles
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

OBJECTIVE: To investigate via the vitamin D status whether patients with peripheral arterial disease (PAD) tend to develop vitamin D deficiency that in turn influences their clinical symptoms.

DESIGN: Cross-sectional.

SETTING: University hospital.

PATIENTS AND PARTICIPANTS: Three hundred twenty-seven patients were evaluated; subjects with secondary causes of bone disease or bone active medication were excluded. One hundred sixty-one patients with either PAD stage II (n = 84) or stage IV (n=77) were enrolled and compared to 45 age- and sex-matched healthy controls.

MEASUREMENTS AND MAIN RESULTS: All patients underwent determinations of serum chemistry, 25-hydroxyvitamin D (vitamin D3) intact parathyroid hormone (iPTH), alkaline phosphatase (ALP), and osteocalcin and were further stratified according to an individual restriction score into 3 groups: mildly, moderately, or severely restricted in daily life due to the underlying disease. Patients with PAD IV showed significantly lower vitamin D3 (P=.0001), and calcium (P=.0001) values and significantly higher iPTH (P=.0001), osteocalcin (P=.0001) and ALP (P=.02) levels as compared to patients with PAD II. Patients considering themselves as severely restricted due to the underlying disease showed lower vitamin D3 and higher iPTH levels than those who described only a moderate (vitamin D3: P<.001; iPTH: P<.01) or mild (vitamin D3: P<.001; iPTH: P<.001) restriction in daily life.

CONCLUSION: Patients with PAD IV, especially those who feel severely restricted due to the disease, are at high risk of developing vitamin D deficiency, secondary hyperparathyroidism, and ultimately osteomalacia due to immobilization and subsequent lack of exposure to sunlight, all of which in turn lead to further deterioration. Monitoring of vitamin D metabolism and vitamin D replacement therapy could be a simple, inexpensive approach to mitigating clinical symptoms and improving quality of life in patients with advanced PAD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Chalmers J, Conacher WD, Gardener DL, Scott PJ. Osteomalacia—a common disease in elderly women. J Bone Joint Surg Br. 1967;49:403–23.

    PubMed  CAS  Google Scholar 

  2. Smith R, Stern G. Myopathy, osteomalacia and hyperparathyroidism. Brain. 1967;90:593–602.

    Article  PubMed  CAS  Google Scholar 

  3. Smith R, Stern G. Muscular weakness in osteomalacia and hyperparathyroidism. J Neurol Sci. 1969;8:511–20.

    Article  PubMed  CAS  Google Scholar 

  4. Mallette LE, Patten BM, Engel WK. Neuromuscular disease in secondary hyperparathyroidism. Ann Intern Med. 1975;82:474–83.

    PubMed  CAS  Google Scholar 

  5. Skaria J, Katiyar BC, Srivastava TP, Dube B. Myopathy and neuropathy associated with osteomalacia. Acta Neurol Scand. 1975;51:37–58.

    Article  PubMed  CAS  Google Scholar 

  6. Schott GD, Wills MR. Muscle weakness in osteomalacia. Lancet. 1976;1:626–9.

    Article  PubMed  CAS  Google Scholar 

  7. Kruse HP. Osteomalazie. In: Allolio B, Schulte HM. Praktische Endokrinologie. München, Wien, Baltimore: Urban u. Schwarzenberg; 1996:302–9.

    Google Scholar 

  8. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet. 1998;351:805–06.

    Article  PubMed  CAS  Google Scholar 

  9. Parfitt AM. Osteomalacia and related disorders. In: Avioli LV, Krane SM, eds. Metabolic Bone Disease 3rd ed. San Diego, Calif: Academic Press; 1998:327–86.

    Google Scholar 

  10. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med. 1998;338:777–83.

    Article  PubMed  CAS  Google Scholar 

  11. Dattani JT, Exton-Smith AN, Stephen JM. Vitamin D status of the elderly in relation to age and exposure to sunlight. Hum Nutr Clin Nutr. 1984;38:131–7.

    PubMed  CAS  Google Scholar 

  12. McKenna MJ, Freaney R, Meade A, Muldowney FP. Hypovitaminosis D and elevated serum alkaline phosphatase in elderly Irish people. Am J Clin Nutr. 1985;41:101–9.

    PubMed  CAS  Google Scholar 

  13. Reid IR, Gallagher DJ, Bosworth J. Prophylaxis against vitamin D deficiency in the elderly by regular sunlight exposure. Age Ageing. 1986;15:35–40.

    Article  PubMed  CAS  Google Scholar 

  14. Egsmose C, Lund B, McNair P, Storm T, Sorensen OH. Low serum levels of 25-hydroxyvitamin D and 1.25-dihydroxyvitamin D in institutionalised old people: influence of solar exposure and vitamin D supplementation. Age Ageing. 1987;16:35–40.

    Article  PubMed  CAS  Google Scholar 

  15. McKenna MJ. Differences in vitamin D status between countries in young adults and the elderly. Am J Med. 1992;93:69–77.

    Article  PubMed  CAS  Google Scholar 

  16. Holick MF. Environmental factors that influence the cutaneous production of vitamin D. Am J Med. 1995;61(3Suppl):638–45.

    Google Scholar 

  17. Holick MF. Vitamin D and bone health. J Nutr. 1996;126(4Suppl):1159–64.

    Google Scholar 

  18. Gloth FM III, Gundberg CM, Hollis BW, Haddad JG Jr., Tobin JD. Vitamin D deficiency in homebound elderly persons. JAMA. 1995;274:1683–6.

    Article  PubMed  Google Scholar 

  19. Gloth FM III, Tobin JD. Vitamin D deficiency in older people. J Am Geriatr Soc. 1995;43:822–8.

    PubMed  Google Scholar 

  20. van der Wielen RP, Lowik MRH, van den Berg H, et al. Serum vitamin D concentrations among elderly people in Europe. Lancet. 1995;346:207–10.

    Article  PubMed  Google Scholar 

  21. Utiger RD. The need for more vitamin D. N Engl J Med. 1998;338:828–9.

    Article  PubMed  CAS  Google Scholar 

  22. Fraser DR. Vitamin D. Lancet. 1995;345:104–7.

    Article  PubMed  CAS  Google Scholar 

  23. Omdahl JL, Garry PJ, Hunsaker LA, Hunt WC, Goodwin JS. Nutritional status in a healthy elderly population: vitamin D. Am J Clin Nutr. 1982;36:1225–33.

    PubMed  CAS  Google Scholar 

  24. Webb AR, Pilbeam C, Hanafin N, Holick MF. An evolution of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Am J Clin Nutr. 1990;51:1075–81.

    PubMed  CAS  Google Scholar 

  25. Salamone LM, Dallal GE, Zantos D, Makrauer F, Dawson-Hughes B. Contributions of vitamin D intake and seasonal sunlight exposure to plasma 25-hydroxyvitamin D concentration in elderly women. Am J Clin Nutr. 1994;58:80–6.

    Google Scholar 

  26. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations and safety. Am J Clin Nutr. 1999;69:825–6.

    Google Scholar 

  27. Preece MA, Tomlinson S, Ribot CA. Studies of vitamin D deficiency in man. Q J Med. 1975;44:575–89.

    PubMed  CAS  Google Scholar 

  28. Lips P, Hackeng WH, Jongen MJ, van Ginkel FC, Netelenbos JC. Seasonal variation in serum concentrations of parathyroid hormone in elderly people. J Clin Endocrinol Metab. 1983;57:204–6.

    PubMed  CAS  Google Scholar 

  29. Lips P, Wiersinga A, van Ginkel FC. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab. 1988;67:644–50.

    PubMed  CAS  Google Scholar 

  30. Dlugos DJ, Perrotta PL, Horn WG. Effects of the submarine environment on renal-stone risk factors and vitamin D metabolism. Undersea Hyperb Med. 1995;22:145–52.

    PubMed  CAS  Google Scholar 

  31. Dawson-Hughes B, Harris SS, Dallal GE. Plasma calcidiol, season and serum parathyroid hormone concentrations in healthy elderly men and women. Am J Clin Nutr. 1997;65:67–71.

    PubMed  CAS  Google Scholar 

  32. Feleke Y, Abdulkadir J, Mshana R, et al. Low levels of serum calcidiol in an African population compared to a North European population. Eur J Endocrinol. 1999;141:358–60.

    Article  PubMed  CAS  Google Scholar 

  33. Sherman SS, Hollis BW, Tobin JD. Vitamin D status and related parameters in a healthy population: the effects of age, sex and season. J Clin Endocrinol Metab. 1990;71:405–13.

    Article  PubMed  CAS  Google Scholar 

  34. Boonen S, Aerssens J, Dequeker J. Age-related endocrine deficiencies and fractures of the proximal femur: II implications of vitamin D deficiency in the elderly. J Endocrinol. 1996;149:13–7.

    Article  PubMed  CAS  Google Scholar 

  35. Stamp TCB, Round JM. Seasonal changes in human plasma levels of 25-hydroxyvitamin D. Nature. 1974;247:563–5.

    Article  PubMed  CAS  Google Scholar 

  36. Lester E, Skinner RK, Wills MR. Seasonal variation in serum-25-hydroxyvitamin D in elderly in Britain. Lancet. 1977;1:979–80.

    Article  PubMed  CAS  Google Scholar 

  37. Juttmann JR, Visser TJ, Buurman C, de Kam E, Birkenhäger JC. Seasonal fluctuations in serum concentrations of vitamin D metabolites in normal subjects. BMJ. 1981;282:1349–52.

    Article  PubMed  CAS  Google Scholar 

  38. Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int. 1997;7:439–43.

    Article  PubMed  CAS  Google Scholar 

  39. Chel VJ, Ooms ME, Popp-Snijders C, et al. Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparthyroidism in the elderly. J Bone Miner Res. 1998;13:1238–42.

    Article  PubMed  CAS  Google Scholar 

  40. Harris SS, Soteriades E, Coolidge JA, Mudgal S, Dawson-Hughes B. Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population. J Clin Endocrinol Metab. 2000;85:4125–30.

    Article  PubMed  CAS  Google Scholar 

  41. Chapuy MC, Schott AM, Garnero P, Hans D, Delmas PD, Meunier PJ, and the EPIDOS STUDY GROUP. Health elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. J Clin Endocrinol Metab. 1996;81:1129–33.

    Article  PubMed  CAS  Google Scholar 

  42. Bischoff H, Stahelin HB, Vogt P, et al. Immobility as a major cause of bone remodeling in residents of a long-stay geriatric ward. Calcif Tissue Int. 1999;64:485–9.

    Article  PubMed  CAS  Google Scholar 

  43. Pfeifer M, Begerow B, Minne HW, et al. Vitamin D status, trunk muscle strength, body sway, falls and fractures among 237 postmenopausal women with osteoporosis. Exp Clin Endocrinol Diabetes. 2001;109:87–92.

    Article  PubMed  CAS  Google Scholar 

  44. Lips P, Duong T, Oleksik A. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab. 2001;86:1212–21.

    Article  PubMed  CAS  Google Scholar 

  45. Glerup H, Mikkelsen K, Poulsen L, et al. Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int. 2000;66:419–24.

    Article  PubMed  CAS  Google Scholar 

  46. Demiaux B, Arlot ME, Chapuy MC, Meunier PJ, Delmas PD. Serum osteocalcin is increased in patients with osteomalacia: correlations with biochemical and histomorphometric findings. J Clin Endocrinol Metab. 1992;74:1146–51.

    Article  PubMed  CAS  Google Scholar 

  47. Ooms ME, Roos JC, Bezemer PD, van der Vijgh WJ, Bouter LM, Lips P. Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab. 1995;80:1052–8.

    Article  PubMed  CAS  Google Scholar 

  48. Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res. 2000;15:1113–8.

    Article  PubMed  CAS  Google Scholar 

  49. Chapuy MC, Arlot ME, Duboeuf F. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med. 1992;327:1637–42.

    Article  PubMed  CAS  Google Scholar 

  50. Chapuy MC, Arlot ME, Delmas PD, Meunier PJ. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ. 1994;308:1081–2.

    PubMed  CAS  Google Scholar 

  51. Meunier PJ, Chapuy MC, Arlot ME, Delmas PD, Duboeuf F. Can we stop bone loss and prevent hip fractures in the elderly? Osteoporos Int. 1994;4(Suppl 1):71–6.

    Article  PubMed  Google Scholar 

  52. Lips P, Graafmans WC, Ooms ME, Bezemer PD, Bouter LM. Vitamin D supplementation and fracture incidence in elderly persons: a randomised, placebo-controlled trial. 1996;124:400–6.

  53. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997;337:670–6.

    Article  PubMed  CAS  Google Scholar 

  54. McDermott MM, Kerwin DR, Liu K, et al. Prevalence and significance of unrecognised lower extremity peripheral arterial disease in general medicine practice. J Gen Intern Med. 2001;16:384–90.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Received from the Department of Internal Medicine, Divisions of Endocrinology, Karl-Franzens University, Graz, Austria

    Astrid Fahrleitner MD, Harald Dobnig MD, Georg Leb MD, Kurt Weber MD & Barbara M. Obermayer-Pietsch MD

  2. Angiology, Karl-Franzens University, Graz, Austria

    Andrea Obernosterer MD & Ernst Pilger MD

  3. the Department of Internal Medicine, Krankenhaus der Barmherzigen Brüder, Vienna, Austria

    Stefan Kudlacek MD

Authors
  1. Astrid Fahrleitner MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Harald Dobnig MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrea Obernosterer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ernst Pilger MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Georg Leb MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kurt Weber MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Stefan Kudlacek MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Barbara M. Obermayer-Pietsch MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Astrid Fahrleitner MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fahrleitner, A., Dobnig, H., Obernosterer, A. et al. Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease. J GEN INTERN MED 17, 663–669 (2002). https://doi.org/10.1046/j.1525-1497.2002.11033.x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1046/j.1525-1497.2002.11033.x

Key words

Search

Navigation